Pancreatic Cancer Research

ResearcherBeckman Research InstituteActive in the last 2 years

Mustafa Raoof

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-4710-2226; OpenAlex author ID A5082080649, A5110289395; NIH RePORTER profile ID 15357872. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 4)
Trials
0
Grants
2
Labs led
2
Collaborators
53
Papers, trials and grants by year

2019: 2 papers · 2020: 1 paper, 1 grant · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 4 papers · 2026: 3 papers, 1 grant

Papers 12

  1. Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41591-026-04625-x↗
  2. Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma Co-author DOI 10.1038/s41591-026-04775-y↗
  3. NEIL2 regulates RNA polymerase II dynamics to suppress transcription–replication conflicts in pancreatic cancer Last author DOI 10.64898/2026.10.19.760262↗
  4. Pancreatic Cancer Immunotherapy: A Team-Based Approach. Co-author DOI 10.1007/978-3-031-97242-3_11↗
  5. Pre-clinical evaluation of a potent and effective Pin1-degrading agent in pancreatic cancer. Co-author DOI 10.1016/j.omton.2025.201078↗
  6. Therapeutic Targeting of Oncogene-Induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1053/j.gastro.2025.02.038↗
  7. Management of Peritoneal Metastasis in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/curroncol32020103↗
  8. Base-excision repair pathway regulates transcription-replication conflicts in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.celrep.2024.114820↗
  9. Advances in Radiation Oncology for Pancreatic Cancer: An Updated Review. Co-author DOI 10.3390/cancers14235725↗
  10. Molecular Targeting of Cancer-Associated PCNA Interactions in Pancreatic Ductal Adenocarcinoma Using a Cell-Penetrating Peptide. Last author DOI 10.1016/j.omto.2020.03.025↗
  11. Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis. Co-author DOI 10.1002/cam4.2491↗
  12. The role of sequential radiation following adjuvant chemotherapy in resected pancreatic cancer. Co-author DOI 10.21037/jgo.2019.01.19↗

Grants 2

  1. Project 2 U54CA285116↗
  2. Targeting Transcription-Replication Conflicts in Pancreatic Cancer AWARD pancan:2020-mustafa-raoof-md-facs-targeting-transcription-replication-conf

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maurizio Pellecchia · 1 shared paper, 1 shared grant, 2025–2026 · strength 1.51
  2. Vincent M. Chung · 7 shared papers, 2019–2026 · strength 1.21
  3. Laleh Golkar Melstrom · 6 shared papers, 2019–2026 · strength 1.12
  4. Fan Meng · 3 shared papers, 2024–2026 · strength 0.63
  5. Terence Marques Williams · 3 shared papers, 2022–2026 · strength 0.58
  6. Yilun Liu · 3 shared papers, 2020–2025 · strength 0.52
  7. Percy P. Lee · 2 shared papers, 2022–2025 · strength 0.43
  8. Marc A. Attiyeh · 2 shared papers, 2024–2026 · strength 0.43
  9. John S. Bolton · 2 shared papers, 2026 · strength 0.39
  10. Caiming Xu · 2 shared papers, 2026 · strength 0.39
  11. Mitsuro Kanda · 2 shared papers, 2026 · strength 0.39
  12. Derek Cridebring · 2 shared papers, 2026 · strength 0.39
  13. Eunsung Jun · 2 shared papers, 2026 · strength 0.39
  14. Giulia Martina Cavestro · 2 shared papers, 2026 · strength 0.39
  15. Carlos Roberto Becerra · 2 shared papers, 2026 · strength 0.39
  16. Douglas B. Evans · 2 shared papers, 2026 · strength 0.39
  17. Haiyong Han · 2 shared papers, 2026 · strength 0.39
  18. David L. Bartlett · 2 shared papers, 2026 · strength 0.39
  19. Alessandro Mannucci · 2 shared papers, 2026 · strength 0.39
  20. Joon Oh Park · 2 shared papers, 2026 · strength 0.39
  21. Erkut Hasan Borazanci · 2 shared papers, 2026 · strength 0.39
  22. Ajay Goel · 2 shared papers, 2026 · strength 0.39
  23. Song Cheol Kim · 2 shared papers, 2026 · strength 0.39
  24. Dong Shang · 2 shared papers, 2026 · strength 0.39
  25. Daniel D. Von Hoff · 2 shared papers, 2026 · strength 0.39

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.